Treatment patterns with any respiratory antibiotic in the 12-month pre-index period were also similar across cohorts, with a slight trend for more antibiotic use in the early BGF adopter cohort; respiratory antibiotics were received by 54.7% of the early BGF adopter cohort, 47.1% of the contemporary BGF user cohort, 44.2% of the FF/UMEC/VI user cohort, and 50.2% of the MITT user cohort.
← all excerpts
Characteristics of Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol or Other Triple Therapies in Japan: A Real-World Healthcare Claims Database Study (MITOS-AURA).
1
—
—